Rare thoracic cancers, including peritoneum mesothelioma.
暂无分享,去创建一个
T. Treasure | S. Siesling | U. Ricardi | J. M. van der Zwan | A. Tavilla | E. Ardanaz | H. Groen | J. Jaal | R. Foschi | I. Izarzugaza
[1] G. Gatta,et al. Rare cancers are not so rare: the rare cancer burden in Europe. , 2011, European journal of cancer.
[2] E. Ruffini,et al. Recurrence of thymoma. , 2011, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[3] L. Wilson,et al. Population Based Cancer Registry Analysis of Primary Tracheal Carcinoma , 2011, American journal of clinical oncology.
[4] A. Marx,et al. Thymic carcinoma: is it a separate entity? From molecular to clinical evidence. , 2011, Thoracic surgery clinics.
[5] A. Scotti,et al. A primary squamous cell carcinoma of the trachea: Case report and review of the literature , 2010, Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale.
[6] A. Darnton,et al. Projection of mesothelioma mortality in Britain using Bayesian methods , 2010, British Journal of Cancer.
[7] A. Burdorf,et al. Assessment of cancer risks due to environmental exposure to asbestos , 2010, Journal of Exposure Science and Environmental Epidemiology.
[8] H. Marres,et al. Clinical aspects and treatment of primary tracheal malignancies , 2010, Acta oto-laryngologica.
[9] M. Coleman,et al. The EUROCARE-4 database on cancer survival in Europe: data standardisation, quality control and methods of statistical analysis. , 2009, European journal of cancer.
[10] Pär Sparén,et al. Occupation and cancer – follow-up of 15 million people in five Nordic countries , 2009, Acta oncologica.
[11] J. Blaauwgeers,et al. Pulmonary tumours in the Netherlands: focus on temporal trends in histology and stage and on rare tumours , 2008, Thorax.
[12] H. Marres,et al. Incidence and Treatment of Tracheal Cancer: A Nationwide Study in The Netherlands , 2007, Annals of Surgical Oncology.
[13] E. Sturgis,et al. Primary tracheal malignant neoplasms: the University of Texas MD Anderson Cancer Center experience. , 2006, Journal of the American College of Surgeons.
[14] M. Coleman,et al. Survival from rare cancer in adults: a population-based study. , 2006, The Lancet. Oncology.
[15] M. Gokhale,et al. Long-term survival after resection of primary adenoid cystic and squamous cell carcinoma of the trachea and carina. , 2004, The Annals of thoracic surgery.
[16] K. Kondo,et al. Lymphogenous and hematogenous metastasis of thymic epithelial tumors. , 2003, The Annals of thoracic surgery.
[17] F. Bray,et al. Pleural mesothelioma incidence in Europe: evidence of some deceleration in the increasing trends , 2003, Cancer Causes & Control.
[18] R. Pfeiffer,et al. Malignant thymoma in the United States: Demographic patterns in incidence and associations with subsequent malignancies , 2003, International journal of cancer.
[19] A. Marx,et al. New WHO histologic classification predicts prognosis of thymic epithelial tumors , 2002, Cancer.
[20] R. De Angelis,et al. Measuring cancer prevalence in Europe: the EUROPREVAL project. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.
[21] Hermann Brenner,et al. Use of period analysis for providing more up-to-date estimates of long-term survival rates: empirical evaluation among 370,000 cancer patients in Finland. , 2002, International journal of epidemiology.
[22] S. Friis,et al. Tracheal cancer in Denmark: a nationwide study. , 2001, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[23] M. Goldberg,et al. Future trends in mortality of French men from mesothelioma , 2000, Occupational and environmental medicine.
[24] N. Harris,et al. Stage III thymoma: pattern of failure after surgery and postoperative radiotherapy and its implication for future study. , 2000, International journal of radiation oncology, biology, physics.
[25] S. Miyoshi,et al. Results of surgical treatment of thymomas with special reference to the involved organs. , 1999, The Journal of thoracic and cardiovascular surgery.
[26] F Levi,et al. The European mesothelioma epidemic , 1999, British Journal of Cancer.
[27] R. Wurm,et al. Thymoma , 1998, Cancer.
[28] P. Tillgren,et al. Maintaining a smoke-free policy: an observational and interview study at a university hospital in Sweden , 1998, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[29] R. De Angelis,et al. Estimating the completeness of prevalence based on cancer registry data. , 1997, Statistics in medicine.
[30] C. Dromer,et al. Prognostic factors and long-term results after thymoma resection: a series of 307 patients. , 1996, The Journal of thoracic and cardiovascular surgery.
[31] J. Peto,et al. Continuing increase in mesothelioma mortality in Britain , 1995, The Lancet.
[32] J. Benichou,et al. Malignant mesothelioma: attributable risk of asbestos exposure. , 1994, Occupational and environmental medicine.
[33] N. Harris,et al. Thymoma: Histologic subclassification is an independent prognostic factor , 1994, Cancer.
[34] M. Haniuda,et al. Adjuvant radiotherapy after complete resection of thymoma. , 1992, The Annals of thoracic surgery.
[35] T. Hakulinen,et al. Cancer survival corrected for heterogeneity in patient withdrawal. , 1982, Biometrics.
[36] G. Gatta,et al. Technical report with basic indicators for rare cancers and health care related macro indicators , 2010 .
[37] L. Michell,et al. Anti-smoking policies and practice in Scottish Health Boards: progress 1985-89. Scottish Tobacco Group. , 1991, Health bulletin.
[38] D. Mathisen,et al. Primary tracheal tumors: treatment and results. , 1990, The Annals of thoracic surgery.
[39] Jacques Ferlay,et al. Cancer incidence in five continents, Volume IX. , 1982 .
[40] J. Ferlay,et al. Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.